GLAXOSMITHKLINE AUSTRALIA PTY LTD

ABN: 47100162481BAYSWATER, VIC
Enterprise ($50M+)
+87.3% YoY
$1.5B
Total Value
5
Total Contracts
Drugs and Pharmaceutical
Primary Category

Recent Contracts

Expiring Soon
Drugs and Pharmaceutical
27 June 2025
CN4164112—Supply of Essential Vaccines to the National Immunisation Program$303.6M

30 June 2025 - 29 June 2026

Department of Health and Aged Care
Expired
Drugs and Pharmaceutical
8 Apr 2025
CN4077601—Supply of Essential Vaccines to the National Immunisation Program$446.1M

30 June 2024 - 29 June 2025

Department of Health and Aged Care
Expired
Drugs and Pharmaceutical
7 Nov 2023
CN3991067—Supply of Essential Vaccines$504.4M

27 July 2023 - 29 June 2024

Department of Health and Aged Care

2 more contracts available

Retender Opportunities

10 retender opportunities found

Expiring contracts in your categories that may be retendered soon.

Peer Benchmarking

See how GLAXOSMITHKLINE AUSTRALIA PTY LTD ranks against similar companies in their category and size band.

Financial Year Breakdown

FY25
$303.6M(1 contracts)
FY24
$950.6M(2 contracts)

2 more years available

Unlock full history →

Company Details

Name
GLAXOSMITHKLINE AUSTRALIA PTY LTD
Also known as
GSK Melbourne, STIEFEL, A GSK COMPANY, STIEFEL, A GSK COMPANY +6 more
Entity Type
Australian Private Company
ABN
47 100 162 481
Town/City
BAYSWATER
Postcode
3153
State/Territory
VIC
Country
Australia

Similar Suppliers

PFIZER AUSTRALIA PTY LTD$760.2MSEQIRUS (AUSTRALIA) PTY LTD$1.8BROCHE PRODUCTS PTY LTD$670.9MSANOFI-AVENTIS AUSTRALIA PTY LTD$538.1MCSL BEHRING (AUSTRALIA) PTY LTD$2.2B